血浆D-二聚体在假体周围关节感染二期翻修中从取出到再植入的反常行为
回顾性分析95例因假体周围关节感染行二期翻修病例中30例有取出前和再植入前D-二聚体结果者,发现再植入前D-二聚体中位百分比变化为升高12.6%,而ESR和CRP分别下降40%和75%,这些标志物变化与再植入结局无显著差异,作者强调外科医生使用D-二聚体做临床决策时应谨慎。
要点
- 再植入前D-二聚体中位百分比变化为升高12.6%(IQR -28.06%至77.3%),而ESR和CRP分别下降40%和75%。
- D-二聚体、ESR和CRP的变化在肌肉骨骼感染学会1/2级与3/4级结局间无显著差异(P分别为0.146、0.946、0.463)。
- 作者强调外科医生使用D-二聚体做临床决策时应谨慎。
核心结论
- 血浆D-二聚体在再植入前反常升高,而其他炎症标志物(ESR/CRP)下降,强调外科医生使用D-二聚体做临床决策时应谨慎。
研究设计与样本
- 回顾性综述纳入95例因假体周围关节感染行二期翻修的连续病例,由3名外科医生在单一机构于2018年至2020年完成手术。
- 纳入标准为取出前和再植入前有D-二聚体结果,最终仅30例再植入被纳入。
- 再植入成功采用肌肉骨骼感染学会结局报告工具定义:1级/2级 vs 3级/4级。
- 采用非参数检验和Mann-Whitney U检验比较Δd-二聚体%(取出前值减再植入前值除以取出前值乘以100)。
- 进行自举法受试者工作特征曲线分析,对30例进行2000次重复。
主要发现
- 取出至再植入的中位时间为86天(四分位距77.7-138.5天)。
- 总体中位百分比变化:D-二聚体升高12.6%(IQR -28.06%至77.3%),ESR下降40%(IQR -70.52%至3.85%),CRP下降75%(IQR -87.43%至-61.34%)。
- 肌肉骨骼感染学会1/2级与3/4级结局间各标志物变化均无显著差异:Δd-二聚体% P=0.146,ΔESR% P=0.946,ΔCRP% P=0.463。
- Δd-二聚体%诊断感染控制的曲线下面积为0.676,表现似乎最佳,但无法解释。
临床怎么用
- 作者强调外科医生使用D-二聚体做临床决策时应谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The variation of plasma d-dimer, an inflammatory marker, from pre-explantation to pre-reimplantation in two-stage revision remains unclear. Our objective was to evaluate delta-changes (Δ) in d-dimer, erythrocyte sedimentation rate (ESR), and C-reactive-protein (CRP), to ascertain whether these delta-changes are associated with the outcome of reimplantation. We hypothesized a decrease in d-dimer before reimplantation. METHODS: A retrospective review was performed on a consecutive series of 95 two-stage revisions indicated for periprosthetic joint infection. Surgeries were performed by 3 surgeons at a single institution (2018-2020). The minimum follow-up was 1 year. The inclusion criteria comprised availability of d-dimer results at pre-explantation and pre-reimplantation. As a result, only 30 reimplantations were included. Success of reimplantation was defined by Musculoskeletal Infection Society outcome reporting tool: Tier 1/Tier 2 vs Tier 3/Tier 4. Nonparametric tests and Mann-Whitney U-tests were conducted to compare Δd-dimer% (pre-explantation value - pre-reimplantation value/pre-explantation value × 100). The bootstrapped receiver operating characteristic curve analyses with 2,000 replicates of 30 cases were conducted. RESULTS: The median time between explantation and reimplantation was 86 days (interquartile range [IQR] = 77.7-138.5 days). Overall, a paradoxical median percent increase (Δd-Dimer% [INCREMENT] = 12.6%) in d-dimer was found from pre-explantation to pre-reimplantation (IQR = -28.06% to 77.3%). However, there was a percentage decrease in ESR (ΔESR% [DECREMENT] = -40%; IQR = -70.52% to 3.85%) and CRP (ΔCRP% [DECREMENT] = -75%; IQR = -87.43% to -61.34%). The changes in all these markers were not different between Musculoskeletal Infection Society Tier 1/2 and 3/4 outcomes (Δd-Dimer%, P = .146; ΔESR%, P = .946; ΔCRP%, P = .463). With area under curve of 0.676, Δd-dimer% (INCREMENT) appeared to be performing best in diagnosing infection control, which was nonexplanatory. CONCLUSION: Plasma d-dimer paradoxically increases before reimplantation while other inflammatory markers (ESR/CRP) decrease, emphasizing that surgeons shall adopt caution using d-dimer to make clinical decisions.
引用
- Pannu TS, Villa JM, Manrique J, et al. Paradoxical Behavior of Plasma d-Dimer From Explantation to Reimplantation in a Two-Stage Revision for Periprosthetic Joint Infection. J Arthroplasty. 2022. PMID: 35158006. doi:10.1016/j.arth.2022.02.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。